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ABSTRACT  The regulation of creatine phosphokinase (CPK) expression by polypeptide growth 
factors  has  been  examined  in the  clonal  mouse  muscle  BC3H1 cell  line.  After arrest  of cell 
growth  by exposure to  low concentrations  of serum,  BC3H1 cells  accumulate  high  levels  of 
muscle-specific  proteins  including  CPK.  The  induction  of this  enzyme  is  reversible  in  the 
presence  of  high  concentrations  of fetal  calf  serum,  which  cause  quiescent,  differentiated 
cells to reenter the cell cycle.  Under these conditions,  the rate of CPK synthesis  is drastically 
reduced.  We  show  in  the  present  communication  that  either  pituitary-derived  fibroblast 
growth factor (FGF) or brain-derived  FGF are as effective  as serum in repressing  the synthesis 
of CPK when added to quiescent, differentiated  cells. The decrease  in the rate of synthesis  of 
CPK occurs within 22 h after the addition of pituitary FGF to the cells.  Pituitary FGF had very 
little effect,  if any, on the rate CPK degradation. The overall  rate of protein synthesis  and the 
pattern  of synthesis  of the  major  polypeptides  made  by these  cells  was not altered  by the 
addition of FGF. Although pituitary FGF was mitogenic for BC3H1 cells, the rate of cell growth 
was not absolutely correlated  with the extent of repression  of CPK.  Brain-derived  FGF fully 
repressed  CPK induction  under conditions where it showed no significant  mitogenic activity. 
These  results  show that the expression of a muscle-specific  protein,  CPK, can  be controlled 
by a single defined polypeptide growth factor in fully differentiated cultures, and that initiation 
of cell division  is not required for their regulation to take place. 
The relationship between cell growth and differentiation has 
been  a  subject  of extensive  investigation  in  a  number  of 
systems. Muscle cells in culture have been a preferred system 
for the investigation of this relationship (3,  11,  19,  26,  28). 
After depletion of mitogens from the culture medium (16), 
muscle cells cease exponential growth and undergo differen- 
tiation (13,  21).  Morphological differentiation is usually ac- 
companied by fusion of mononucleated myoblasts into mul- 
tinucleated myotubes and by the expression of a number of 
muscle-specific proteins including myosin and other compo- 
nents of the contractile apparatus as well as creatine phospho- 
kinase (CPK)' and the acetylcholine receptor (3,  18,  19, 28). 
In examining the relationship between growth and induc- 
tion, a number of investigations have demonstrated the use- 
fulness of causing quiescent,  differentiated myoblasts under 
' Abbreviations  used in this paper: B-CPK, brain isozyme of CPK; 
CPK, creatine phosphokinase; DME, Dulbecco's modified Eagle's 
medium; FCS, fetal calf serum; FGF, fibroblast growth factor; LSM, 
low-serum medium; M-CPK, muscle isozyme of CPK. 
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nonfusing conditions to reenter the cell cycle in response to a 
mitogenic stimulation (3-5, 22-25).  A  cell  line particularly 
suitable for these studies is the muscle-like cell line, BC3H 1. 
After growth is arrested at moderate cell densities by exposure 
to low levels of fetal calf serum (FCS) the cells differentiate as 
defined by the expression of high concentrations of CPK as 
well as other muscle-specific proteins including the acetylcho- 
line receptor; however, unlike myoblasts, these cells  do not 
fuse (20,  30).  Differentiation in this system has been shown 
to be reversible. That is, nongrowing cells that are induced to 
synthesize muscle-specific proteins will reinitiate cell growth 
in response to high levels of serum with a concomitant loss 
of the differentiated phenotype (23-25). This repression  2 ap- 
pears to involve both transcriptional (23,  24) and posttrans- 
2  Induction and repression are used to indicate situations in which 
the cells synthesize or fail to synthesize muscle-specific  proteins. No 
particular mechanism of regulation is implied by these terms. Fur- 
thermore, repression in this context should not be confused with the 
use of the term to represent a temporal delay of differentiation. 
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bly of the acetylcholine receptor (25). 
The use of serum as a  mitogenic stimulus has significant 
disadvantages in the study of the molecular events associated 
with  the  loss  of the  differentiated  phenotype.  Serum  is  a 
complex mixture of molecules, and a biological effect brought 
about by the addition  of serum to cells cannot be assigned 
unequivocally to a particular serum component. We therefore 
have developed a  medium for BC3H 1 cells which supports 
cell viability and differentiation in the presence of trace con- 
centrations of serum. We present evidence in this paper that 
this medium supplemented with pituitary fibroblast growth 
factor (FGF)  specifically induces  cell  growth  in  quiescent 
BC3H l cells, and that the synthesis of a muscle-specific pro- 
tein, CPK, is rapidly repressed. Repression is also observed 
after addition of another polypeptide growth factor, the acidic 
form of brain  FGF,  3 but without significant stimulation of 
cell growth. 
MATERIALS AND  METHODS 
Materials:  Trypsin (Type III), bovine insulin, human transferrin,  fatty 
acid-free  bovine serum albumin (BSA) (No. A-7511), and collagen (Type III) 
were from Sigma Chemical Co. (St. Louis, MO). FGF was from Collaborative 
Research, lnc. (Waltham,  MA). FCS and antibiotics were from Gibeo Labora- 
tories (Grand Island, NY). High glucose/high bicarbonate  Dulbecco's modified 
Eagle's medium (DME)  was from the Washington  University  Basic Cancer 
Research Center (St. Louis, MO). Culture dishes and flasks were from Falcon 
Labware (Oxnard, CA). Epidermal growth factor was prepared by the method 
of Savage and  Cohen  (29). Highly  purified  platelet-derived  growth  factor 
(PDGF) was the generous gift of  Dr. Thomas F. Deuel (Washington University). 
Acidic brain  FGF (31) purified  by high-performance  liquid  chromatography 
was the kind gift of Dr. Kenneth A. Thomas (Merck Sharp & Dohme Div., 
Rahway, N  J). 
Insulin was dissolved in  12 mM HC1 to a concentration  of 1 mg/ml and 
was stored  at -70"C. Transferrin  was dissolved in phosphate-buffered  saline 
(PBS) to  l0 mg/ml and was stored at -20"C. FGF was prepared and stored 
according to manufacturer's instructions. Fatty acid-free BSA was dissolved in 
PBS at 25 mg/ml and was stored at 4"C. All solutions were stored in polypro- 
pylene containers and were filter sterilized when appropriate.  Repeated freeze- 
thawing was avoided. 
Cell Culture:  The BC3H 1 muscle-like cell line (30) was grown in DME 
supplemented with 20% FCS, 100 U/ml penicillin, and 100 #g/ml streptomycin 
in a humidified atmosphere  of 10% CO2 and 90% air at 37"C. Cultures were 
re-fed every 2 d. Subeonfluent  stocks were subeultured  every 4-5 d at a split 
ratio  of-1:20.  To subculture,  we first  washed  cultures  with  calcium-  and 
magnesium-free  solution  at  37"C. 2  ml  of 0.05% trypsin,  0.02% disodium 
ethylenediamine  tetraacetic acid in calcium- and magnesium-free solution  at 
37"C was spread evenly over the cells and was immediately aspirated. After 90 
s, cells were resuspended  by gentle agitation  in warm 20%  FCS. Cells were 
either pelleted at 600 rpm for 3 min and resuspended, or plated directly in 20% 
FCS with  no apparent difference in growth  or morphology.  35-mm culture 
dishes were used and were collagen coated  as described previously (20). Cell 
numbers were determined  with a Coulter  counter (Coulter  Electronics, Inc., 
Hialeah, FL). 
Biochemical Procedures:  CPK was assayed spectrophotometrically 
as described previously (26). Cell homogenates were prepared in l ml of 50 nM 
glycylglycine, pH 6.75, 1% Nonidet  P40 and were assayed under conditions of 
activity that were linear with respect to time and protein concentration. 
To determine  the rate of CPK synthesis, we labeled cells for 3 or 4 h with 
L-[35S]methionine (New England Nuclear,  Boston, MA) as described (23). At 
the end of the labeling period, cells were harvested and extracted with Triton 
X-100 into  a  final volume  of 400 ~l, and CPK was immunoprecipitated  as 
described previously (23). The commercial antiserum used for the precipitation 
of CPK precipitates both the brain isozyme (B-CPK) and the muscle isozyme 
(M-CPK).  The  isozymes were  easily separated  by  SDS  polyacrylamide  gel 
electrophoresis (14) on the basis of their relatively large difference in molecular 
weights (26). The gels were subjected to fluorography, and the relative rate of 
synthesis was determined  by densitometry  of the  M-  and  B-CPK bands as 
3 Unless  otherwise specified, all references to FGF refer to the pituitary 
form. 
described (23).  Individual cultures were  used for each immunoprecipitation, 
and equal volumes of immunoprecipitated material were used for electropho- 
resis.  Rates of total  protein  synthesis were  determined by  precipitation  of 
labeled extracts with trichloroacetic acid (23). 
RESULTS 
To study the role of purified growth factors in the regulation 
of growth and differentiation in BC3H l cells, we developed a 
simplified medium that would allow the cells to retain viabil- 
ity and  normal  rates  of CPK  synthesis  in  the  absence  of 
mitogens, but upon supplementation with mitogens, would 
allow the cells to grow at levels comparable to that seen with 
DME that contained 20% FCS. The medium that was devel- 
oped contains a trace quantity of FCS, 0.25% without which 
the viability of the cells could not be maintained (data not 
shown).  This medium, designated as LSM (low-serum me- 
dium), contains DME and Fl2  in a  ratio of 3:1,  50 #g/ml 
transferrin, 250 ~tg/ml BSA, and antibiotics. As shown in Fig. 
1 A, the morphology of quiescent cells in this medium resem- 
bled that of differentiated cells in DME that contained  1% 
FCS (see reference 30). As will be shown below, induction of 
CPK and overall protein synthesis continued at a rate com- 
parable to that in  DME that contained  1%  FCS.  Collagen 
coating allowed excellent adhesion of cells to the substratum 
but had no effect on the rate of growth or induction in this 
system. 
A  variety of growth  factors that  have been shown to be 
mitogenic for muscle cells (6, 9, 10,  12, 33) or other cell types 
were tested for their ability to reinitiate growth of quiescent 
cultures  of BC3H1  cells  in  LSM.  Significant  cell  growth, 
comparable to that observed upon the addition of 20% FCS, 
was observed only when a combination of FGF and insulin 
was added to the cells (Fig.  2A). The substances tested that 
had no mitogenic activity included PDGF, epidermal growth 
factor, dexamethasone, and linoleic acid bound to fatty acid- 
free  BSA.  These  compounds  added  to  the  medium  either 
alone  or  in  various  combinations  had  no  effect  on  CPK 
activity. For example, 48 h after addition of pituitary FGF to 
LSM that contained insulin, there was a 60% increase in cell 
number; addition of 50 ng/nl PDGF to LSM + insulin (1 ~g/ 
ml) resulted in no increase in cell number relative to LSM 
that contained insulin.  In the same experiment, addition of 
20% FCS resulted in a doubling of  cell number in 48 h. PDGF 
also had no effect on the rate of synthesis of M-CPK, mea- 
sured  as  described  in  Materials  and  Methods,  20  h  after 
addition of PDGF. 
FGF dramatically decreased the  rate of accumulation  of 
CPK when added to differentiated cells in LSM (Fig. 2 B). As 
in the case of 20% FCS, CPK activity in the culture continued 
to increase for -  1 d after addition of FGF and then remained 
constant. We have previously demonstrated that all cells in 
differentiated cultures are synthesizing CPK (23), thus repres- 
sion of CPK activity must represent an effect on cells that 
have already entered the differentiation process rather than 
an inhibition of entry of additional cells into that process. 
The effects of different combinations of insulin and FGF 
on cell growth and CPK activity are summarized in Table I. 
FGF repressed CPK activity if added alone, when the mito- 
genic effect was weak, or with insulin, when the rate of  growth 
was comparable to that observed in 20%  FCS.  In contrast, 
insulin had a small but significant mitogenic effect compara- 
ble to that observed upon addition of FGF alone, but it did 
not inhibit the accumulation of CPK.  Rather,  it showed a 
small increase in the level of  CPK. These observations indicate 
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response  to  hormonal  supplements. 
CeII growth was arrested and cultures 
were  allowed to  differentiate as  de- 
scribed in Materials and Methods. Cul- 
tures were then re-fed with the exper- 
imental media, and fresh medium was 
added at 20 h. Photographs  show cul- 
ture morphology after 40 h in the me- 
dium indicated. (A) Cultures in LSM; (B) 
cultures  in  LSM  supplemented  with 
200 ng/ml FGF; (C) LSM with FGF and 
1 ug/ml  insulin;  (D)  LSM  with  acidic 
brain  FGF  at  10  ng/ml  and  1  ~.g/ml 
insulin; (E) 20% serum. Phase-contrast 
pictures, x  27. 
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FIGURE  2  Effects  of  hormones on  cell growth and  CPK  activity 
accumulation. Cultures were plated in  20% serum as described. 
On day  I, cultures were re-fed with medium that contained I% 
serum (arrow). Cell number is shown in A and CPK activity in B. 
The culture medium was then replaced at the times indicated by 
the arrows with the various experimental  media. Cell numbers were 
determined in duplicate with a Coulter counter. CPK was deter- 
mined as described in Materials and Methods from duplicate ex- 
tracts.  Unless  otherwise indicated, error bars  were smaller than 
symbols. Insulin  was present at I/~g/ml and FGF at 200 ng/ml. 
that the degree of repression of CPK activity is not absolutely 
correlated  with  the  rate  of cell  growth.  The  concentration 
dependence of FGF for the repression of CPK and for cell 
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FIGURE  3  Dependence of cell growth and CPK activity on concen- 
tration of FGF. Induced cultures were treated with LSM  supple- 
mented with I  t~g/ml insulin and FGF at concentrations indicated. 
Fresh medium was added 20 h later. Cell numbers were determined 
45 h after re-feeding. CPK activity was determined from duplicate 
extracts 40 h after re-feeding. Unless otherwise indicted, error bars 
are smaller  than symbors. CPK activity and cell number in 20% FCS 
controls are indicated by arrows. TABLE  I 
Effect of Fibroblast Growth Factor on CPK Activity and Cell 
Growth 
CPK (% maximal  Percent increase in 
Medium  activity)  cell number 
LSM  75 _-. 3  (n =  6)  -- 
LSM +  insulin  100 ___ 4  (n =  8)  29 +  6  (n =  9) 
LSM +  insulin  +  FGF  55 ___ 5  (n =  7)  75 __+ 8  (n =  7) 
LSM+FGF  49__+ 1 (n=3)  28_+5(n=3) 
1% FCS/DME  96 +  15 (n =  6)  -- 
20%  FCS/DME  41  +  4  (n =  7)  128 ___ 18 (n =  8) 
Quiescent,  differentiated cultures were re-fed as in  Fig. 2  with  the experi- 
mental  medium  indicated.  CPK  activity  was determined  at 40  h  after the 
medium  change.  Results  are expressed as relative units normalized to the 
activity in LSM +  insulin (n represents the number of separate experiments). 
The error between  determinations from  duplicate  extracts was <10%  and 
usually ~4%. Cell number is expressed as the percent increase over control 
levels by 48 h.  In  the case of LSM +  insulin and LSM +  insulin +  FGF, the 
reference value is the culture condition  in LSM.  In  the case of 20% serum, 
the reference value is the culture in 1% FCS. Cell number typically showed 
no increase after 48 h in either LSM or 1% FCS; however, in some experiments 
cell number increased by as much as 20% in these media. Insulin was present 
at 1 /~g/ml and FGF at 0.2/~g/ml. 
growth in shown in Fig. 3. The concentration dependence for 
both effects is similar; a half-maximal response is observed at 
~20 ng/ml. 
FGF  affected  the  morphology of the  cells,  as  shown  by 
comparison of A and B of Fig.  1. Cultures treated with FGF 
developed a flattened, fibroblastic morphology characteristic 
of exponentially growing cells (30). A similar change in mor- 
phology was seen when 20%  FCS was added to the cells, as 
shown in E. Since FGF produced this effect in the presence 
or absence of insulin, a strong mitogenic effect does not seem 
to be required for this change to occur. Inspection of Fig.  1  B 
shows that  most cells in  the culture assumed a  fibroblastic 
morphology in response to FGF. 
FGF  could  affect  the  rate  of accumulation  of CPK  by 
affecting either the rate of synthesis or the rate of degradation. 
Fig.  4 shows the effects of 20%  FCS and LSM supplemented 
with insulin and FGF on the rate of CPK synthesis at various 
times after their addition to induced cultures.  5  h  after the 
addition  of either  20%  FCS  or FGF,  the  rate  of M-CPK 
synthesis was equal to or higher than that for controls. By 22 
FIGURE  4  Time  dependence  of  the  ef- 
fects  of  FGF  and  FCS  on  the  rate  of M- 
CPK  synthesis.  Cultures  were  re-fed  with 
DME  supplemented  with  FCS at the  con- 
centrations  indicated  or with  LSM supple- 
mented  with  1 /~g/ml  insulin or 200 ng/ml 
FGF as indicated.  Duplicate  cultures were 
pulse-labeled for 3 h with  [3SS]methionine, 
CPK was immunoprecipitated,  and the iso- 
zymes  were  resolved  by  gel  electropho- 
resis.  The  numbers  above the  lanes  indi- 
cate the time (in hours) at the midpoint  of 
each pulse period.  (M,  muscle  isozyme of 
CPK; B, brain isozyme of CPK.) 
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than in control cultures. Table II summarizes several experi- 
ments in which the rate of CPK synthesis was measured 22 h 
TABLE  II 
Effect of Growth Factors and FC5 on the Rates of CPK Synthesis 
and Protein Synthesis 
Relative rate 
of overall 
Relative rate of M-  protein syn- 
Medium  CPK  synthesis  thesis 
LSM  80-+ 6  (n =  4/  76 ±  3 
LSM +  insulin  100 ±  9  (n =  5)  100 ±  6 
LSM +  insulin  +  FGF  35  +  6  (n =  5)  102 ±  2 
1% FCS/DME  78 ±  15 (n =  5)  59 ±  2 
20%  FCS/DME  20 4- 6  (n =  5)  122 ±  7 
The rate of M-CPK synthesis was determined by densitometry of fluorographs 
prepared as described in Fig. 2. All values have been normalized to LSM + 
insulin.  Abreviation used are the same as those in  Fig. 2.  n  represents the 
number of experiments performed; duplicate extracts were  made  in each 
experiment. The rate of overall protein synthesis was determined by trichlo- 
roacetic  acid  precipitation  of  7.5  pl  from  cell  extracts and  are  duplicate 
determinations from a  representative experiment, Counts per minute  have 
been normalized to LSM +  insulin (100% =  4 x  10  ~ cpm of [3SS]methionine/ 
dish). 
after the addition of various mitogens or hormones to induced 
BC3H 1 ceUs. FGF, either alone or in the presence of insulin, 
repressed the rate of M-CPK synthesis to levels comparable 
to that observed in the presence of 20%  FCS.  FGF did not 
significantly affect the rate of synthesis of the major polypep- 
tides in BC3HI  cells, as shown by one-dimensional gel elec- 
trophoresis (Fig.  5),  which  indicates  that  repression of M- 
CPK synthesis does not reflect a general decrease or alteration 
in  protein  synthesis.  The  relative  increase  in  total  protein 
synthesis due  to addition  of insulin  or 20%  FCS  varied  in 
different  experiments,  but in  no ease did  addition  of FGF 
cause a significant change in the overall rate of protein syn- 
thesis.  In  most experiments,  insulin  stimulated  the  rate  of 
overall protein synthesis by 20-30%.  The lower levels of B- 
CPK and the occasional presence of co-migrating trace con- 
taminants precluded precise quantitation of this isozyme, but 
its level was less sensitive to addition of FGF than that of M- 
CPK (see,  for example,  Fig.  4). These results show that the 
rate of M-CPK synthesis in the presence of FGF is reduced 
to a level comparable to that observed after the addition of 
20% FCS. 
To determine whether the rate of degradation of M-CPK 
was also affected by the addition of mitogens, we pulse labeled 
FIGURE  5  Effect  of  growth  factors 
on the overall pattern of protein syn- 
thesis.  Quiescent,  differentiated  cul- 
tures were  re-fed  with  the  medium 
indicated.  At the  times  indicated  (in 
hours),  cultures  were  labeled  with 
[3SS]methionine  for  4  h  and  ex- 
tracted.  A  10-p.l  aliquot  from  an  ex- 
tract of 400/~I volume was subjected 
to electrophoresis. 
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turnover. Quiescent, differentiated cultures 
were  washed  with  methionine-free  DME 
and  were pulse-labeled for 4  h  with  100 
~Ci/ml t-[3SS]methionine in 0.5 ml methio- 
nine-free DME containing 1"/, dialyzed fetal 
calf serum and 20 #M unlabeled  t-methio- 
nine. The pulse medium was removed, the 
cultures  were  washed  with  DME,  and  the 
various  experimental  media  were  added. 
Cells  were  harvested  and  extracted  20  h 
later.  CPK  was  immunoprecipitated  and 
equal volumes from each extract were elec- 
trophoresed,  to  represents  cultures  that 
were  harvested  and  immunoprecipitated 
immediately at the end of the pulse period. 
BCaHI cells with [3SS]methionine  for 4 h. At the end of the 
labeling period, the pulse medium was removed, and cultures 
were re-fed with media that contained FCS or with LSM that 
contained various hormonal supplements. After 20 h, extracts 
were prepared and CPK was immunoprecipitated. As shown 
in Fig.  6, the rate of turnover, as determined by the amount 
of  undegraded radiolabeled CPK, was approximafley  the same 
in all conditions. Approximately 50% of the CPK radioactiv- 
ity was lost after 20  h.  Turnover was slightly enhanced  in 
20%  FCS,  as  has  been  seen  previously in  the  laboratory 
(Caldwell, K., unpublished observations). 
Pituitary FGF and brain FGF are distinct molecules (1, 21) 
and, although both are mitogens for fibroblasts (8,  31),  the 
exact biological relationship between then is as yet unclear. 
The possibility that brain FGF is a minor contaminant of the 
pituitary FGF preparation cannot be excluded. We have tested 
brain  FGF to  determine whether it  could  also repress the 
synthesis of CPK in BC3H 1 cells, and, as shown in Fig. 7, the 
acidic form of brain FGF at a concentration of 10 ng/ml was 
at least as effective as 20% FCS in repressing CPK synthesis. 
Densitometry of the fluorograph shown in  Fig.  7  indicated 
that the relative rate of M-CPK synthesis in LSM that con- 
tained insulin and brain FGF was 12% the rate observed in 
cells that contained LSM plus insulin (Table II). Brain FGF 
had  no  effect on  the  rate  of overall protein  synthesis (not 
shown), and it promoted the same change in morphology as 
that observed with pituitary FGF and FCS (Fig.  1  C).  Fig.  8 
illustrates the dependence of the rate of M-CPK synthesis on 
the concentration of brain FGF added 20 h previously. Under 
these conditions,  the addition  of 5  ng/ml of brain FGF to 
LSM  or LSM  supplemented with  1 #g/ml insulin  did  not 
cause any detectable increase in cell number. 
DISCUSSION 
A variety of environmental factors modulate cell differentia- 
tion. Cells interact with the substratum, with other cells, and 
with a  variety of media components (hormones and  mito- 
gens), all of which influence the developmental process. To 
investigate these effects, it is important to examine the effects 
of single defined environmental components on cell differ- 
entiation and, if possible, to quantitate the effect by measure- 
ments of the quantity or activity of well-characterized mole- 
cules associated with the differentiated phenotype. The obser- 
vations presented in this paper describe a unique system for 
such investigations. Two defined mitogens (one highly puri- 
fied,  brain  FGF)  influence  differentiation  in  BC3H1  cells, 
defined by the synthesis of a  muscle-specific protein, the M 
isozyme of CPK. These mitogens drastically decrease the rate 
of synthesis of M-CPK to levels comparable to that observed 
upon  addition  of 20%  FCS  to the  same cells.  The rate  of 
degradation of M-CPK and the rate of overall protein synthe- 
sis in these cells remain relatively unaffected by these mito- 
gens. The decreased rate of M-CPK synthesis after addition 
LATHI~OF' [7 ^L.  ConttolofMuscte Differentiation  "~545 FIGURE  7  Effect of brain FGF on the rate of CPK synthesis. Cultures 
and extracts were treated exactly as described in  Fig. 4. Cultures 
were  pulse-labeled 22  h  after the  addition of the  experimental 
media. A, 20% serum;/3, LSM +  1 #g/ml insulin and supplemented 
with 10 ng/ml acidic brain FGF; C, LSM +  1 ~tg/ml insulin +  200 ng/ 
ml pituitary FGF; and D, I_SM +  1 /zg/ml inslulin. 
of growth factor observed in these studies, coupled with the 
turnover of M-CPK, adequately accounts for the cessation of 
CPK accumulation after addition of mitogen. 
In previous experiments from this laboratory, we examined 
the rate of M-CPK synthesis 48 h after addition of 20% FCS 
to differentiated cultures (23) and observed an increased rate 
of CPK  synthesis  even though  the  level  of CPK  in  these 
cultures was reduced.  It appears that the  increased level of 
CPK synthesis represented the early stages of reinduction of 
these cells as they reached high cell densities in 20% FCS (20), 
which had not yet led to the accumulation of additional CPK 
in the cells. All measurements of the rate of M-CPK synthesis 
in  this  paper  were  Confined  to  early  times  (,<20, h)  after 
addition of mitogens. 
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FIGURE  8  Dependence of the rate 
of M-CPK synthesis on the concen- 
tration of brain  FGF. Induced cul- 
tures in I% serum were re-fed with 
LSM supplemented with I p.~/ml in- 
sulin and brain FGF at the concen- 
trations indicated. The  rate  of  M- 
CPK synthesis was determined  from 
duplicate  extracts  20  h  after  re- 
feeding, as  described in  Materials 
and  Methods.  The  solvent added 
with 10 ng/ml brain FGF (2 p.M tri- 
fluoracetic acid, 0.01% acetonitrile) 
had no effect on the rate of M-CPK 
synthesis. 
Investigations in a  number of laboratories have examined 
the  relationship between  cell growth  and  differentiation  in 
muscle cells. Nyguyen et al. (22) have isolated a temperature- 
sensitive muscle cell line which, at the nonpermissive temper- 
ature, synthesizes muscle-specific proteins but does not irre- 
versibly commit to differentiation. Similar to what is observed 
with BC3H 1 cells, the addition of serum reinitiates growth in 
these cells and represses muscle-specific gene expression. The 
factors in serum that were responsible for repression were not 
identified  in  these  experiments;  however,  the  addition  of 
pituitary FGF has been shown to be sufficient to delay the 
onset  of  myogenic  induction  by  prolonging  exponential 
growth (9,  15, 16, 32), although high rates of cell proliferation 
were shown to be unnecessary for FGF to block the onset of 
differentiation (17). 
An inhibitor of muscle differentiation that is not mitogenic 
has  been  described  by  Evinger-Hodges et  al.  (7),  but  its 
mechanism of action is not known. Similarly, previous results 
from this laboratory have described a  crude serum fraction 
which is not mitogenic for cells but blocks differentiation in 
BC3H1 cells (20). 
Because of the  apparent inverse correlation between  cell 
growth  and  cell  differentiation,  we  examined  a  variety  of 
known mitogenic molecules to ascertain whether they could 
replace serum as  a  factor which  causes repression of CPK 
synthesis, and found both the pituitary FGF and the acidic 
form of brain FGF to be effective in this regard, even though 
they are distinct molecules with rather different properties. 
Even though these  molecules were selected for study be- 
cause  of their  potential  mitogenic activity,  the  correlation 
between mitogen activity and repression of CPK synthesis is 
poor, and brain FGF appears not to be mitogenic for BC3H 1 
cells under our assay conditions. Thus, while the subcellular 
signals generated by the binding of these mitogens to a recep- 
tor may be the same for cell growth and for repression of cell 
differentiation, cell growth per se appears not to be required 
for the control of the synthesis of M-CPK and, by inference, 
for  the  control  of the  repression  of other  gene  products 
characteristic of differentiated BC3H 1 cells. 
Mitogenic polypeptides, when added to quiescent cells such 
as fibroblasts in the Go phase of the cell cycle, induce a series 
of sequential events which, 8-12 h later, result in the initiation 
of DNA synthesis and ultimately cell division (27).  Differen- 
tiating BC3HI cells are arrested early in the G~ phase of the 
cell cycle (Lathrop,  B.,  unpublished  observation). We may 
therefore  speculate  that  synthesis  of differentiated  proteins 
such as M-CPK is only possible in the metabolic environment 
of cells in Go. Addition of mitogenic polypeptides alters this environment so that synthesis of M-CPK is no longer possible, 
presumably because mRNA synthesis for this molecule ceases, 
and existing mRNA is degraded. We have shown previously 
that  addition  of  20%  FCS  to  differentiating  BCaH1  cells 
decreases the level of translatable M-CPK messenger extract- 
able from these cells, and the decrease in the rate of M-CPK 
synthesis observed in the present experiments presumably is 
a measure of M-CPK message  in these cells.  In this simple 
model, transit through the cell cycle is not required for FGF 
to exert its effect,  and simply changing the cellular composi- 
tion (proteins, ions, pH) from that in cells at Go will have the 
effect  of preventing  further synthesis of M-CPK.  In  other 
words,  partial  transit through GI  will  block differentiation. 
Experiments are in progress  to critically test this model. As 
an example, there have been recent observations that adeno- 
virus 2EIA protein, a c-myc-like protein, can enhance as well 
as block transcription of different genes (2). The increase in 
the concentration of such proteins brought about as a result 
of the addition of growth factor to cells might serve  both to 
initiate  transit  through the  cell  cycle  while  simultaneously 
blocking transcription of genes associated with cell differen- 
tiation. 
Although the receptor or receptors for FGF in these and 
other cells  remain  to be  characterized,  it  seems  likely that 
they will share characteristics  in common with better charac- 
terized mitogen receptors, which are tyrosine-specific protein 
kinases and rapidly stimulate a number of metabolic events 
in cells, including activation of ion fluxes, etc. It would be of 
considerable interest, in light of the specific effects of FGF on 
the differentiation of BC3H 1 cells, to better characterize the 
interaction of FGF with these cells, including characterization 
of the receptor and of the early events that follow the inter- 
action of FGF with its receptor(s). 
This work was supported by grant GM  18405 from the National 
Institutes of Health. 
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